Clinical Research Directory
Browse clinical research sites, groups, and studies.
EMERALD (Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders)
Sponsor: Wake Forest University Health Sciences
Summary
The EMERALD intervention involves 1) ordering an Emergency Department (ED) lipid panel, 2) calculating 10-year Atherosclerotic cardiovascular disease (ASCVD) risk using the Pooled Cohort Equations, 3) prescribing a moderate- or high-intensity statin if applicable, and 4) referring patients to outpatient care (primary care, preventive cardiology, or general cardiology, depending on risk level).
Key Details
Gender
All
Age Range
40 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
22
Start Date
2023-03-08
Completion Date
2023-07-15
Last Updated
2026-10-02
Healthy Volunteers
No
Conditions
Interventions
moderate- or high-intensity statin/ rosuvastatin
moderate- or high-intensity statin (either rosuvastatin 10mg daily or rosuvastatin 40 mg daily)
Locations (1)
Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States